- Decreased ARID1A expression is correlated with chemoresistance in epithelial ovarian cancer
-
Yokoyama Y, Matsushita Y, Shigeto T, Futagami M, Mizunuma H
- KMID: 1811189
- J Gynecol Oncol.
- 2014 Jan;25(1):58-63.
- doi: 10.3802/jgo.2014.25.1.58
OBJECTIVE: Loss of ARID1A is related to oncogenic transformation of ovarian clear cell adenocarcinoma. The present study was conducted in epithelial ovarian cancer of all tissue types to investigate whether... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan
-
Matsumoto , Shimokawa , Nasu K, Shikama A, Shiozaki T, Futagami M, Kai K, Nagano H, Mori T, Yano M, Sugino N, Fujimoto E, Yoshioka N, Nakagawa S, Shimada M, Tokunaga H, Yamada Y, Tsuruta T, Tasaki K, Nishikawa , Kuji S, Motohashi , Ito K, Yamada T, Teramoto N
- KMID: 2458905
- J Gynecol Oncol.
- 2019 Nov;30(6):e103.
- doi: 10.3802/jgo.2019.30.e103
OBJECTIVE: We conducted a retrospective, multi-institutional, collaborative study to accumulate cases of neuroendocrine carcinoma of the endometrium, to clarify its clinicopathologic features, treatment, prognosis and prognostic factors to collate findings... -
- CITED
-
- Close
- SHARE
-
- Close
